bioMerieux SA (bioMerieux), a subsidiary of Institut Merieux SA, develops, manufactures, and markets in vitro diagnostic solutions for hospital and private laboratories. The company offers diagnostic solutions such as systems, reagents and software for the diagnosis of infectious diseases, cardiovascular diseases and cancers, besides identifying microorganisms in pharmaceuticals, cosmetics, and agri-food products. It offers immunoassays, microbiology products, molecular biology tests and other solutions for clinical applications and industrial microbiological control solutions for the food, biopharmaceutical, and cosmetic industries; veterinary diagnostic laboratories; and blood banks. bioMerieux also provides solutions for the enumeration of bacterial flora, which indicate the quality of food products. The company distributes its products directly and through a network of distributors across the world. bioMerieux is headquartered in Marcy l’Etoile, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company bioMerieux SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- bioMerieux SA Company Overview
- bioMerieux SA Company Snapshot
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA - Pipeline Analysis Overview
- Business Description
- bioMerieux SA - Key Facts
- bioMerieux SA - Major Products and Services
- bioMerieux SA Pipeline Products by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Pipeline Products Overview
- Annexin A3 Prostate Cancer Marker
- Annexin A3 Prostate Cancer Marker Product Overview
- Argene Sars-Cov-2 R-Gene Test
- Argene Sars-Cov-2 R-Gene Test Product Overview
- BIOFIRE R/ST PANEL
- BIOFIRE R/ST PANEL Product Overview
- Biomarker Test - Chronic Q Fever
- Biomarker Test - Chronic Q Fever Product Overview
- BRAF - Breast Cancer Diagnostic Kit
- BRAF - Breast Cancer Diagnostic Kit Product Overview
- Clinical Digital Solution
- Clinical Digital Solution Product Overview
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
- Diagnostic Assay - Alcoholism
- Diagnostic Assay - Alcoholism Product Overview
- Diagnostic Assay - Alzheimer's Disease
- Diagnostic Assay - Alzheimer's Disease Product Overview
- Diagnostic Assay - Amyotrophic Lateral Sclerosis
- Diagnostic Assay - Amyotrophic Lateral Sclerosis Product Overview
- Diagnostic Assay - Depression
- Diagnostic Assay - Depression Product Overview
- Diagnostic Assay - Huntington’s Disease
- Diagnostic Assay - Huntington’s Disease Product Overview
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy Product Overview
- Diagnostic Assay - Neuro ICU Monitoring
- Diagnostic Assay - Neuro ICU Monitoring Product Overview
- Diagnostic Assay - Parkinson's Disease
- Diagnostic Assay - Parkinson's Disease Product Overview
- Diagnostic Assay - Prostate Cancer
- Diagnostic Assay - Prostate Cancer Product Overview
- Diagnostic Assay - Seizure
- Diagnostic Assay - Seizure Product Overview
- Diagnostic Assay - Stroke
- Diagnostic Assay - Stroke Product Overview
- Diagnostic Test - Abdominal Pain
- Diagnostic Test - Abdominal Pain Product Overview
- Diagnostic Test - Acute Coronary Syndrome
- Diagnostic Test - Acute Coronary Syndrome Product Overview
- Diagnostic Test - Acute Respiratory Infection
- Diagnostic Test - Acute Respiratory Infection Product Overview
- Diagnostic Test - Cerebrovascular Injury
- Diagnostic Test - Cerebrovascular Injury Product Overview
- Diagnostic Test - Sepsis
- Diagnostic Test - Sepsis Product Overview
- Diagnostic Test - Shaken Baby Syndrome (SBS)
- Diagnostic Test - Shaken Baby Syndrome (SBS) Product Overview
- FilmArray 2.0 - Lower Respiratory Tract Panel
- FilmArray 2.0 - Lower Respiratory Tract Panel Product Overview
- FilmArray Febrile Infant Panel
- FilmArray Febrile Infant Panel Product Overview
- FilmArray Pneumonia Panel
- Product Status
- FilmArray Sepsis Direct Panel
- FilmArray Sepsis Direct Panel Product Overview
- FilmArray Sepsis Direct Panel Clinical Trial
- FilmArray STD Panel
- FilmArray STD Panel Product Overview
- Hylia
- Hylia Product Overview
- iMAG
- iMAG Product Overview
- ISIT-TB Assay
- ISIT-TB Assay Product Overview
- ISIT-TB Assay Clinical Trial
- Nephroclear CCL14 Test
- Nephroclear CCL14 Test Product Overview
- Nephroclear CCL14 Test Clinical Trial
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
- NucliSENS EasyQ Legionella spp Molecular Test
- NucliSENS EasyQ Legionella spp Molecular Test Product Overview
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
- Spec80
- Spec80 Product Overview
- SpecID System
- SpecID System Product Overview
- Totem
- Totem Product Overview
- VIDAS CXCL9 CDx
- VIDAS CXCL9 CDx Product Overview
- Vidas hsCRP Assay
- Vidas hsCRP Assay Product Overview
- VIDAS TB-IGRA
- VIDAS TB-IGRA Product Overview
- bioMerieux SA - Key Competitors
- bioMerieux SA - Key Employees
- bioMerieux SA - Key Employee Biographies
- bioMerieux SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- bioMerieux SA, Recent Developments
- Jul 02, 2024: Specific Diagnostics Receives 510(K) Clearance For VITEK REVEAL GN AST Assay
- Jul 02, 2024: Specific Diagnostics Receives 510(K) Clearance For VITEK REVEAL
- Jun 26, 2024: Biomérieux Receives U.S. FDA Special 510(K) Clearance and Clia-Waiver for Its Biofire Spotfire Respiratory/Sore Throat (R/St) Panel Mini
- Jun 19, 2024: bioMerieux Receives 510(K) Clearance For VITEK 2 AST-Yeast Anidulafungin (= 8 µg/mL)
- Jun 18, 2024: BioFire Diagnostics Receives 510(K) Clearance For BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini
- Jun 11, 2024: USDA Awards bioMerieux GENE-UP CAMPLYLOBACTER as Method of Choice for Campylobacter Detection in USDA Food Safety and Inspection Service Laboratories
- May 28, 2024: bioMerieux receives FDA 510(k) clearance of VIDAS TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
- May 23, 2024: Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
- May 17, 2024: bioMerieux SA Receives 510(K) Clearance For VIDAS TBI
- Apr 09, 2024: bioMerieux Announces First-Quarter 2024 Business Review
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA Pipeline Products by Equipment Type
- bioMerieux SA Pipeline Products by Indication
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA, Key Facts
- bioMerieux SA, Major Products and Services
- bioMerieux SA Number of Pipeline Products by Development Stage
- bioMerieux SA Pipeline Products Summary by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Ongoing Clinical Trials Summary
- Annexin A3 Prostate Cancer Marker - Product Status
- Annexin A3 Prostate Cancer Marker - Product Description
- Argene Sars-Cov-2 R-Gene Test - Product Status
- Argene Sars-Cov-2 R-Gene Test - Product Description
- BIOFIRE R/ST PANEL - Product Status
- BIOFIRE R/ST PANEL - Product Description
- Biomarker Test - Chronic Q Fever - Product Status
- Biomarker Test - Chronic Q Fever - Product Description
- BRAF - Breast Cancer Diagnostic Kit - Product Status
- BRAF - Breast Cancer Diagnostic Kit - Product Description
- Clinical Digital Solution - Product Status
- Clinical Digital Solution - Product Description
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
- Diagnostic Assay - Alcoholism - Product Status
- Diagnostic Assay - Alcoholism - Product Description
- Diagnostic Assay - Alzheimer's Disease - Product Status
- Diagnostic Assay - Alzheimer's Disease - Product Description
- Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Status
- Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Description
- Diagnostic Assay - Depression - Product Status
- Diagnostic Assay - Depression - Product Description
- Diagnostic Assay - Huntington’s Disease - Product Status
- Diagnostic Assay - Huntington’s Disease - Product Description
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy - Product Status
- Diagnostic Assay - Hypoxic Ischemic Encephalopathy - Product Description
- Diagnostic Assay - Neuro ICU Monitoring - Product Status
- Diagnostic Assay - Neuro ICU Monitoring - Product Description
- Diagnostic Assay - Parkinson's Disease - Product Status
- Diagnostic Assay - Parkinson's Disease - Product Description
- Diagnostic Assay - Prostate Cancer - Product Status
- Diagnostic Assay - Prostate Cancer - Product Description
- Diagnostic Assay - Seizure - Product Status
- Diagnostic Assay - Seizure - Product Description
- Diagnostic Assay - Stroke - Product Status
- Diagnostic Assay - Stroke - Product Description
- Diagnostic Test - Abdominal Pain - Product Status
- Diagnostic Test - Abdominal Pain - Product Description
- Diagnostic Test - Acute Coronary Syndrome - Product Status
- Diagnostic Test - Acute Coronary Syndrome - Product Description
- Diagnostic Test - Acute Respiratory Infection - Product Status
- Diagnostic Test - Acute Respiratory Infection - Product Description
- Diagnostic Test - Cerebrovascular Injury - Product Status
- Diagnostic Test - Cerebrovascular Injury - Product Description
- Diagnostic Test - Sepsis - Product Status
- Diagnostic Test - Sepsis - Product Description
- Diagnostic Test - Shaken Baby Syndrome (SBS) - Product Status
- Diagnostic Test - Shaken Baby Syndrome (SBS) - Product Description
- FilmArray 2.0 - Lower Respiratory Tract Panel - Product Status
- FilmArray 2.0 - Lower Respiratory Tract Panel - Product Description
- FilmArray Febrile Infant Panel - Product Status
- FilmArray Febrile Infant Panel - Product Description
- Product Status
- FilmArray Pneumonia Panel - Product Description
- FilmArray Sepsis Direct Panel - Product Status
- FilmArray Sepsis Direct Panel - Product Description
- FilmArray Sepsis Direct Panel - The Clinical and Pharmacoeconomic Impact of Rapid Diagnostic Test (Multiplex PCR FilmArray) on Antimicrobial Decision Making Compared to Conventional Decision Making Among Critically Ill Patients
- FilmArray STD Panel - Product Status
- FilmArray STD Panel - Product Description
- Hylia - Product Status
- Hylia - Product Description
- iMAG - Product Status
- iMAG - Product Description
- ISIT-TB Assay - Product Status
- ISIT-TB Assay - Product Description
- ISIT-TB Assay - Early Risk Assessment in TB Contacts by New Diagnostic Tests
- Nephroclear CCL14 Test - Product Status
- Nephroclear CCL14 Test - Product Description
- Nephroclear CCL14 Test - A Sample Collection Study to Validate the NEPHROCLEAR CCL14 Test
- Nephroclear CCL14 Test - A Urine Sample Collection Study in Apparently Healthy Adults and Adults With Chronic, Stable Morbidities
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
- NucliSENS EasyQ Legionella spp Molecular Test - Product Status
- NucliSENS EasyQ Legionella spp Molecular Test - Product Description
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
- Spec80 - Product Status
- Spec80 - Product Description
- SpecID System - Product Status
- SpecID System - Product Description
- Totem - Product Status
- Totem - Product Description
- VIDAS CXCL9 CDx - Product Status
- VIDAS CXCL9 CDx - Product Description
- Vidas hsCRP Assay - Product Status
- Vidas hsCRP Assay - Product Description
- VIDAS TB-IGRA - Product Status
- VIDAS TB-IGRA - Product Description
- bioMerieux SA, Key Employees
- bioMerieux SA, Key Employee Biographies
- bioMerieux SA, Subsidiaries
- Glossary
- bioMerieux SA Pipeline Products by Equipment Type
- bioMerieux SA Pipeline Products by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Sysmex Corp
- Bio-Rad Laboratories Inc
- Siemens Healthineers AG
- Ortho Clinical Diagnostics Holdings Plc
- Eurofins Scientific SE
- Becton Dickinson and Co
- Abbott Laboratories
- OpGen Inc
- F. Hoffmann-La Roche Ltd
- Danaher Corp
